Suven Life Sciences Limited (NSE:SUVEN)
India · Delayed Price · Currency is INR 278.25
-1.70 (-0.61%)
Nov 11, 2026, 1:14 PM IST
Suven Life Sciences Market Cap
Suven Life Sciences has a market cap or net worth of 78.72 billion as of November 10, 2026. Its market cap has increased by 84.91% in one year.
Market Cap
78.72B
Enterprise Value
75.41B
Revenue
189.73M
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since July 31, 2002, Suven Life Sciences's market cap has increased from 1.61B to 78.72B, an increase of 4,784.98%. That is a compound annual growth rate of 17.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 78.72B | 107.41% |
| Dec 31, 2025 | 37.95B | 35.97% |
| Dec 31, 2024 | 27.91B | 58.69% |
| Dec 29, 2023 | 17.59B | 17.75% |
| Dec 30, 2022 | 14.94B | 31.72% |
| Dec 31, 2021 | 11.34B | -1.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eris Lifesciences | 174.19B |
| Cohance Lifesciences | 169.68B |
| NATCO Pharma | 157.92B |
| Sudeep Pharma | 136.10B |
| Akums Drugs and Pharmaceuticals | 117.12B |
| Strides Pharma Science | 92.18B |
| Aarti Pharmalabs | 83.70B |
| Sun Pharma Advanced Research Company | 68.41B |